Apollo Endosurgery Inc (APEN) - Financial and Strategic SWOT Analysis Review

June 2019 | 48 pages | ID: A90B1C93260EN
GlobalData

Abstracts

Apollo Endosurgery Inc (APEN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – Analyst’s summarization of the company’s business strategy.
• SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
• Key manufacturing facilities – A list of key manufacturing facilities of the company.
• Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
• Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Apollo Endosurgery Inc (Apollo Endosurgery) formerly Lpath Inc is a medical technology company that designs, develops and commercializes medical devices used for the treatment of obesity. The company’s product portfolio comprises endo-bariatric products such as Orbera Intragastric Balloon System; and OverStitch endoscopic suturing system. These non-surgical interventional devices are also used in procedures that address or repair a variety of gastrointestinal defects. Apollo Endosurgery's products serve bariatric surgeons and gastroenterologists in providing interventional therapy for obesity and associated co-morbidities; closure of acute perforations and chronic fistulas; tissue closure after the removal of abnormal lesions in the esophagus, stomach or colon; inadvertent perforation of the GI tract; and in the treatment of swallowing disorders and also to suture in place esophageal stents for preventing their migration. It has a manufacturing facility in the Coyol Free Trade Zone in Alajuela, Costa Rica. Apollo Endosurgery is headquartered in Austin, Texas, the US.

Apollo Endosurgery Inc Key Recent Developments

May 02,2019: Apollo Endosurgery reports first quarter 2019 results
Mar 26,2019: Apollo Endosurgery names John Barr to Board of Directors
Mar 18,2019: Apollo Endosurgery reports fourth quarter and full year 2018 results
Nov 08,2018: Apollo Endosurgery reports third quarter 2018 results
Aug 08,2018: Apollo Endosurgery reports second quarter 2018 results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

• The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

• The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

• Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

• Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

• Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Contents

SECTION 1 - ABOUT THE COMPANY

Apollo Endosurgery Inc - Key Facts
Apollo Endosurgery Inc - Key Employees
Apollo Endosurgery Inc - Key Employee Biographies
Apollo Endosurgery Inc - Major Products and Services
Apollo Endosurgery Inc - History
Apollo Endosurgery Inc - Company Statement
Apollo Endosurgery Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
Apollo Endosurgery Inc - Business Description
Product Category: Endo-Bariatric
Overview
Performance
Product Category: Other
Performance
Product Category: Surgical
Overview
Performance
Geographical Segment: Outside the US
Performance
Geographical Segment: The US
Performance
R&D Overview
Apollo Endosurgery Inc - Corporate Strategy
Apollo Endosurgery Inc - SWOT Analysis
SWOT Analysis - Overview
Apollo Endosurgery Inc - Strengths
Apollo Endosurgery Inc - Weaknesses
Apollo Endosurgery Inc - Opportunities
Apollo Endosurgery Inc - Threats
Apollo Endosurgery Inc - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Apollo Endosurgery Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Apollo Endosurgery Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Apollo Endosurgery Inc, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

May 02, 2019: Apollo Endosurgery reports first quarter 2019 results
Mar 26, 2019: Apollo Endosurgery names John Barr to Board of Directors
Mar 18, 2019: Apollo Endosurgery reports fourth quarter and full year 2018 results
Nov 08, 2018: Apollo Endosurgery reports third quarter 2018 results
Aug 08, 2018: Apollo Endosurgery reports second quarter 2018 results
Jun 25, 2018: Two diabetes medications don’t slow progression of type 2 diabetes in youth
May 31, 2018: Apollo Endosurgery Appoints Dr. Julie Shimer to Board of Directors
May 03, 2018: Apollo Endosurgery Reports First Quarter 2018 Results
Mar 01, 2018: Apollo Endosurgery Reports Fourth Quarter and Full Year 2017 Results

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

Apollo Endosurgery Inc, Key Facts
Apollo Endosurgery Inc, Key Employees
Apollo Endosurgery Inc, Key Employee Biographies
Apollo Endosurgery Inc, Major Products and Services
Apollo Endosurgery Inc, History
Apollo Endosurgery Inc, Other Locations
Apollo Endosurgery Inc, Subsidiaries
Apollo Endosurgery Inc, Key Competitors
Apollo Endosurgery Inc, Ratios based on current share price
Apollo Endosurgery Inc, Annual Ratios
Apollo Endosurgery Inc, Annual Ratios (Cont...1)
Apollo Endosurgery Inc, Interim Ratios
Apollo Endosurgery Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Apollo Endosurgery Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Apollo Endosurgery Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

LIST OF FIGURES

Apollo Endosurgery Inc, Performance Chart (2014 - 2018)
Apollo Endosurgery Inc, Ratio Charts
Apollo Endosurgery Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Apollo Endosurgery Inc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019

COMPANIES MENTIONED

Steris Plc
Spatz FGIA, Inc
Olympus Corp
Obalon Therapeutics Inc
Medtronic Plc
Medicone
Johnson & Johnson
Cook Medical Inc
Boston Scientific Corp
Allurion Technologies, Inc.